{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:55:09Z","timestamp":1780048509080,"version":"3.53.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.pbb.2009.03.003","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T11:51:36Z","timestamp":1237463496000},"page":"649-654","source":"Crossref","is-referenced-by-count":25,"title":["The supra-additive hyperactivity caused by an amphetamine\u2013chlordiazepoxide mixture exhibits an inverted-U dose response: Negative implications for the use of a model in screening for mood stabilizers"],"prefix":"10.1016","volume":"92","author":[{"given":"Michele P.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheree F.","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Majchrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adedayo","family":"Adedoyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Rosenzweig-Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Comery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2009.03.003_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01271291","article-title":"A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission","volume":"104","author":"Agmo","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2009.03.003_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2004.08.015","article-title":"Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania","volume":"158","author":"Arban","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2009.03.003_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0028-3908(71)90074-8","article-title":"Evaluation of a rapid technique for detecting minor tranquilizers","volume":"10","author":"Aron","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00217062","article-title":"Hyperactivity induced by dexamphetamine\/chlordiazepoxide mixtures in rats and its attenuation by lithium pretreatment: a role for dopamine?","volume":"91","author":"Aylmer","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1196\/annals.1397.081","article-title":"Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study","volume":"1096","author":"Bielau","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pbb.2009.03.003_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0006-8993(93)90801-S","article-title":"Circadian phase-shifts induced by chlordiazepoxide without increased locomotor activity","volume":"622","author":"Biello","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2009.03.003_bib7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v65n0813","article-title":"Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder","volume":"65","author":"Boylan","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biopsych.2006.05.005","article-title":"Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography","volume":"60","author":"Cannon","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(93)90266-K","article-title":"Magnesium valproate attenuates hyperactivity induced by dexamphetamine\u2013chlordiazepoxide mixture in rodents","volume":"237","author":"Cao","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2009.03.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","article-title":"Animal models of mood disorders: recent developments","volume":"20","author":"Cryan","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.psc.2005.02.003","article-title":"Treatment of bipolar depression","volume":"28","author":"Dubovsky","year":"2005","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pbb.2009.03.003_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0269881106060241","article-title":"Modelling facets of mania\u2014new directions related to the notion of endophenotypes","volume":"20","author":"Einat","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2009.03.003_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10519-006-9093-4","article-title":"Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease","volume":"37","author":"Einat","year":"2007","journal-title":"Behav Genet"},{"key":"10.1016\/j.pbb.2009.03.003_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.pnpbp.2007.03.005","article-title":"Bipolar disorder: how far are we from a rigorous definition and effective management?","volume":"31","author":"Emilien","year":"2007","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00213-005-2163-0","article-title":"The psychopharmacology of impulsive behaviour in rats VIII: effects of amphetamine, methylphenidate, and other drugs on responding maintained by a fixed consecutive number avoidance schedule","volume":"180","author":"Evenden","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pbb.2008.02.007","article-title":"In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity","volume":"89","author":"Foreman","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2009.03.003_bib17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1176\/appi.ajp.2007.05122032","article-title":"Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD","volume":"164","author":"Goldberg","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.neubiorev.2007.05.007","article-title":"Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement","volume":"31","author":"Gould","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2009.03.003_bib19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1301254","article-title":"Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium","volume":"32","author":"Gould","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib20","first-page":"577","article-title":"Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test","volume":"54","author":"Gould","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2004.01.017","article-title":"Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures","volume":"84","author":"Hantouche","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2009.03.003_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00213-004-2028-y","article-title":"Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests","volume":"178","author":"Hogan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I dirsorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2009.03.003_bib25","first-page":"5","article-title":"Prevalence and impact of comorbid anxiety and bipolar disorder","volume":"67","author":"Keller","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib26","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1021\/ja068969w","article-title":"Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. Possible new GSK-3beta therapies for bipolar disorders","volume":"129","author":"Kozikowski","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pbb.2009.03.003_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/ebeh.2001.0254","article-title":"Effect of the new antiepileptic drug levetiracetam in an animal model of mania","volume":"2","author":"Lamberty","year":"2001","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pbb.2009.03.003_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2003.11.017","article-title":"Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression","volume":"55","author":"Lawrence","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib29","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4088\/JCP.v69n0605","article-title":"Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD","volume":"69","author":"Marangell","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0893-133X(01)00244-5","article-title":"Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent","volume":"25","author":"Millan","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2009.03.003_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/229135a0","article-title":"Regular induction of hypomania by L-dopa in \u201cbipolar\u201d manic-depressive patients","volume":"229","author":"Murphy","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2009.03.003_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.neubiorev.2007.04.002","article-title":"The behavioral actions of lithium in rodent models: leads to develop novel therapeutics","volume":"31","author":"O'Donnell","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2009.03.003_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bjp.bp.104.007773","article-title":"Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders","volume":"189","author":"Otto","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2165\/00002018-199512020-00007","article-title":"Drug-induced mania","volume":"12","author":"Peet","year":"1995","journal-title":"Drug Safety"},{"key":"10.1016\/j.pbb.2009.03.003_bib35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.pnpbp.2005.11.036","article-title":"The four-plates test: anxiolytic or analgesic paradigm?","volume":"30","author":"Ripoll","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib36","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/2111312a0","article-title":"Combined effects of chlordiazepoxide and dexamphetamine on activity of rats in an unfamiliar environment","volume":"211","author":"Rushton","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2009.03.003_bib37","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pbb.2009.03.003_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yebeh.2005.08.017","article-title":"Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats","volume":"7","author":"Shannon","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pbb.2009.03.003_bib39","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.161.12.2222","article-title":"Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"161","author":"Simon","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1399-5618.2007.00408.x","article-title":"Risk of suicide attempt and suicide death in patients treated for bipolar disorder","volume":"9","author":"Simon","year":"2007","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pbb.2009.03.003_bib42","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4088\/JCP.v68n1002","article-title":"Self-reported history of manic\/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"68","author":"Truman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2009.03.003_bib43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","article-title":"A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor","volume":"31","author":"Young","year":"2007","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709000963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305709000963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T01:50:56Z","timestamp":1545357056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305709000963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0091305709000963"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2009.03.003","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}